APA (7th ed.) Citation

Waissi, W., Burckel, H., Magisson, E., Larderet, G., & Noel, G. (2017). PO-0987: Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells. Radiotherapy & Oncology, 123, S545. https://doi.org/10.1016/S0167-8140(17)31423-8

Chicago Style (17th ed.) Citation

Waissi, W., H. Burckel, E. Magisson, G. Larderet, and G. Noel. "PO-0987: Gemcitabine-based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells." Radiotherapy & Oncology 123 (2017): S545. https://doi.org/10.1016/S0167-8140(17)31423-8.

MLA (9th ed.) Citation

Waissi, W., et al. "PO-0987: Gemcitabine-based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells." Radiotherapy & Oncology, vol. 123, 2017, p. S545, https://doi.org/10.1016/S0167-8140(17)31423-8.